Serpin family A member 1 is an oncogene in glioma and its translation is enhanced by NAD(P)H quinone dehydrogenase 1 through RNA-binding activity

Author:

Liu Wenjun1,Du Min1,Wan Hongping1,Yang Hao2,Deng Xiaorong2,Chen Yu1,Zhang Qian1

Affiliation:

1. Department of Neurology, Hubei No. 3 People’s Hospital of Jianghan University , Wuhan , Hubei , China

2. Department of Neurology, Hubei No. 3 People’s Hospital of Jianghan University , No. 26 Zhongshan Avenue, Qiaokou District , Wuhan , Hubei , China

Abstract

AbstractSerpin family A member 1 (SERPINA1) is expressed abundantly in gliomas and can predict unfavorable prognosis of patients with glioma. Studies have shown that nicotinamide adenine dinucleotide phosphate quinone dehydrogenase 1 (NQO1) can promote the proliferation of glioblastoma multiforme cells and enhance the expression ofSERPINA1, but its effects on glioma cells remain unknown. In this study, we explored the functions ofSERPINA1in glioma tumorigenesisin vitroand then investigated whetherNQO1affects the protein expression ofSERPINA1and its mRNA level. The results showed that the translation ofSERPINA1was suppressed while its mRNA level had no significant changes under the condition ofNQO1silencing. Luciferase reporter assay and biotin pull-down assay further indicated thatNQO1bond withSERPINA13′ untranslated region. miR-1321 was also identified to targetSERPINA1, repressing its mRNA and protein levels. SERPINA1andNQO1promoted glioma cell proliferation and suppressed cell apoptosis. Moreover,SERPINA1rescued the effects of sh-NQO1 in glioma cell malignant phenotypes. In conclusion, our findings showed that oncogeneNQO1and antioncogene miR-1321 bind to oncogeneSERPINA1to affect proliferation and apoptosis of glioma cells, which can bring new solution of antitumor treatments for glioma in the future.

Publisher

Walter de Gruyter GmbH

Subject

General Medicine

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Impact of NQO1 dysregulation in CNS disorders;Journal of Translational Medicine;2024-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3